|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||79.58 - 81.99|
|52-week range||71.90 - 97.85|
|PE ratio (TTM)||21.21|
|Earnings date||29 Jan. 2018 - 2 Feb. 2018|
|Forward dividend & yield||1.52 (1.96%)|
|1y target est||90.90|
AmerisourceBergen (ABC) strives to strengthen core businesses. The H. D. Smith buyout is likely to strengthen the Pharmaceutical Distribution Segment.
Solid growth in the Pharmaceutical Distribution Services segment drove AmerisourceBergen's (ABC) top line in the fourth quarter.
AmerisourceBergen's (ABC) strong performance in the Pharmaceutical Distribution Services segment is a positive. The company issued guidance for fiscal 2018.
AmerisourceBergen'S (ABC) growth story is expected to be stunted by tepid performance at PharMEDium. Also steep competition is a cause of concern.
VALLEY FORGE, Pa.--(BUSINESS WIRE)--Dec. 22, 2016-- AmerisourceBergen Corporation (NYSE:ABC) has been notified of an unsolicited 'mini-tender' offer by TRC Capital Corporation ('TRC') to purchase up to ...
Current Report no. 33/2016 Issue date: 2016-12-08 Legal basis: Art. 17(1) of the Regulation (EU) no. 596/2014 of 16 April 2014 of the European Parliament and Council on market abuse (Market Abuse Regulation) ...
Current Report no. 31/2016 Issue Date: 2016-11-22 Legal Basis: Art. 19(3) of the Regulation (EU) no. 596/2014 of 16 April 2014 of the European Parliament and Council on market abuse (Market Abuse Regulation) ...
Current Report no. 32/2016 Issue Date: 2016-12-07 Legal Basis: Art. 56(1)(2) of the Act on Public Offering - current and periodic information Subject: Changes in the composition of the Company's Supervisory ...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--Dec. 19, 2016-- AmerisourceBergen Corporation (NYSE: ABC) today announced that Keri Mattox will join the Company as Vice President, Corporate & Investor Relations, effective ...